Skip ahead to page content

federal_budget_and_spending.jpg

Going forward in Iraq

December 7, 2006 | By Nathaniel Ward

Yesterday, the Iraq Study Group released its much-anticipated report on America’s involvement in Iraq. While the report breaks little new ground, it helps clarify the debate on how to prevail in Iraq.

“Its recommendations comprise a sensible and realistic way forward in Iraq, with one major exception,” Heritage experts James Phillips and James Carafano explain. “Drawing Syria and Iran into efforts to stabilize Iraq would accomplish little at great expense or even backfire, undermining stability.”

Click here for more analysis of what the ISG got right—and wrong.

The new Secretary of Defense

Yesterday, the Senate overwhelmingly approved Robert Gates as Secretary of Defense. Secretary Gates will replace Donald Rumsfeld, whose presided over the first years of the war on terrorism and began the essential reforms that will transform the military into a 21st-century fighting force.

Mackenzie Eaglen and James Carafano, who work as defense analysts at The Heritage Foundation, explain that the new Pentagon chief focused on the right issues during his confirmation hearings.

Click here to read more about the new Secretary of Defense’s policy positions.

No room for ‘negotiation’

Many liberals campaigned this year on a pledge to allow the government to “negotiate” the prices of medicines seniors purchase under the costly new Medicare prescription drug entitlement. This may be good rhetoric, but it’s terrible policy, as Heritage health care expert Bob Moffit explains.

“There’s a lot wrong with the Medicare drug program,” Moffit argues. “But the intense competition that takes place among health plans offering drug coverage today isn’t one of them.” The private insurers who currently purchase drugs have already negotiated steep discounts from drug companies and kept premiums down, he notes, “and the nonpartisan Congressional Budget Office doesn't think the Medicare bureaucracy would do better.”

Government “negotiation” would mean that government would fix drug prices. The likely method of enforcing the fixed price would be crude: Congress would simply block entry to any company that wouldn't or couldn't accept the government's fixed price, and companies wouldn't be able to sell to seniors in Medicare. That’s bad news for seniors depending on newer and more effective drugs sold by companies locked out of the Medicare “market.”

It turns out that drug companies charge what they do for a very good reason. Click here to find out why.

In other news

Coming up at Heritage

To attend these or any other Heritage Foundation events, RSVP at Heritage’s events website. Or you can watch these events live online at Heritage.org. All times are Eastern.

Nathaniel Ward is the Editor of MyHeritage.org—a website for members and supporters of The Heritage Foundation.